News

Boston Scientific Corp. and Asahi Intecc have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire. 

Medtronic, Acist Agreement FFR-IVUS Technologies

Acist Medical Systems entered into a strategic agreement with Medtronic to co-promote the world’s first Rapid Exchange FFR (RXi) and high definition IVUS (HDi) technologies in the United States....

July 24, 2014 — Boston Scientific has initiated full commercial launch of its new Polaris imaging system. This system will support the Boston Scientific family of intravascular ultrasound (IVUS)...

June 5, 2014 — New measures of the severity of coronary artery blockages do not provide enough accuracy to guide treatment decisions, according to the results of the VERIFY-2 study presented as a...

FDA Clearnace Volcano Corp. iFR Modality FFR Catheter Cath Lab

Volcano Corp. announced U.S. Food and Drug Administration (FDA) clearance of its proprietary Instant Wave-Free Ratio (iFR) modality.

Acist RXi Rapid Exchange FFR System April 2014 ACC.14

Acist Medical Systems Inc. announced at the American College of Cardiology's 63rd Annual Scientific Session in Washington, D.C., the global introduction of the new Acist|RXi Rapid Exchange...

FFR, Volcano

Comprised of the cardiologist and the heart surgeon, the heart team collaboratively assesses and determines the best course of treatment for cardiac patients. ECHI has a large and successful...

intravascular imaging ffr ultrasound ivus optical coherence tomography oct cath

In an expert consensus document e-published in Catheterization and Cardiovascular Interventions (CCI), the Society for Cardiovascular Angiography and Interventions (...

cath lab clinical trial study fraction flow reserve FFR

study supports the use of instantaneous wave-free ratio (iFR) to simplify assessment and determine the severity of coronary...

The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2013...

cath lab, SYNTAX, SCAI

The year 2013 has brought us several important clinical trials that have changed the way interventional cardiologists approach and treat patients with stable coronary artery disease. These trials...

Preliminary results from the ADVISE (Adenosine Vasodilator Independent Stenosis Evaluation) II trial confirm prior retrospective publications and demonstrate the clinical usefulness of an iFR/...

St. Jude Medical gained CE mark approval of its Ilumien Optis percutaneous coronary intervention (PCI) optimization system to better visualize stent planning and navigation. The system integrates...

In the current era of healthcare reform and increasing requirements to follow appropriate use criteria, any technology that offers a basic yes or no answer to whether a patient should be treated...

My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology and trends. With collaboration from my Editorial Advisory Board, we developed a 2013...

January 11, 2013 — Guided Interventions LLC, a startup company developing new, easier to use fractional flow reserve (FFR) a product to help cardiologists better assess the physiological impact of...

December 26, 2012 — St. Jude Medical Inc. announced the first patient enrollment in its ILUMIEN I clinical study. The observational study is designed to show the optimal way optical coherence...

Corindus CorPath robotic system

Hospitals constantly try to predict what the future holds when planning new facilities and equipment purchases that need to last for the next decade. Martin Leon, M.D., attempted to answer that...

The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report investigations that will be presented at next month's ...